2008PubMedOpen access

[The expression of Skp2 in human non-small cell lung cancer and its correlation with expression of p27 protein.].

Xiaohua Hu, Feng Liu, Bin Jiang, Yajie Wang

Open full text 3 citations

Abstract

BACKGROUND: S-phase kinase-associated protein 2 (Skp2) is one of the positive regulators of the cell cycle that promote Ubiquitin-mediated proteolysis of the cyclin-dependent kinase inhibitor p27. Its overexpression has been implicated in tumorigenesis. In this study, we investigated the expression of Skp2 in human nonsmall cell lung cancer (NSCLC) and its relationship with expression of p27 protein. METHODS: The expression of Skp2 and p27 protein were detected in 68 NSCLC, 17 normal bronchial epithelium by the tissue chip and immunohistochemistry technology. RESULTS: Skp2 was only expressed in NSCLC patients, there was closely relationship among Skp2 expression and histological subtype, cellular differentiation, sex and smoking; Otherwise, there was no relationship among skp2 expression and age or TNM stage. The expression of p27 protein was found in normal bronchial epithelial cells, and the expression was reduced in NSCLC. The expression of p27 was significantly reduced in patients with positive expression of Skp2. Expression of Skp2 was negatively correlated with expression of p27. CONCLUSIONS: The expression of Skp2 is up-regulated in NSCLC, and overexpression of Skp2 reduces the protein level of p27 through ubiquitin-dependent degradation, indicating Skp2 may play an important role in oncogenesis and development of NSCLC.

About this research paper

What this paper is about

BACKGROUND: S-phase kinase-associated protein 2 (Skp2) is one of the positive regulators of the cell cycle that promote Ubiquitin-mediated proteolysis of the cyclin-dependent kinase inhibitor p27. Its overexpression has been implicated in tumorigenesis. In this study, we investigated the expression of Skp2 in human nonsmall cell lung cancer (NSCLC) and its relationship with expression of p27 protein. METHODS: The expression of Skp2 and p27 protein were detected in 68 NSCLC, 17 normal bronchial epithelium by the tissue chip and immunohistochemistry technology. RESULTS: Skp2 was only expressed in NSCLC patients, there was closely relationship among Skp2 expression and histological subtype, cellular differentiation, sex and smoking; Otherwise, there was no relationship among skp2 expression and age or TNM stage. The expression of p27 protein was found in normal bronchial epithelial cells, and the expression was reduced in NSCLC. The expression of p27 was significantly reduced in patients with positive expression of Skp2. Expression of Skp2 was negatively correlated with expression of p27. CONCLUSIONS: The expression of Skp2 is up-regulated in NSCLC, and overexpression of Skp2 reduces the protein level of p27 through ubiquitin-dependent degradation, indicating Skp2 may play an important role in oncogenesis and development of NSCLC.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

BACKGROUND: S-phase kinase-associated protein 2 (Skp2) is one of the positive regulators of the cell cycle that promote Ubiquitin-mediated proteolysis of the cyclin-dependent kinase inhibitor p27. Its overexpression has been implicated in tumorigenesis. In this study, we investigated the expression of Skp2 in human nonsmall cell lung cancer (NSCLC) and its relationship with expression of p27 protein. METHODS: The expression of Skp2 and p27 protein were detected in 68 NSCLC, 17 normal bronchial epithelium by the tissue chip and immunohistochemistry technology. RESULTS: Skp2 was only expressed in NSCLC patients, there was closely relationship among Skp2 expression and histological subtype, cellular differentiation, sex and smoking; Otherwise, there was no relationship among skp2 expression and age or TNM stage. The expression of p27 protein was found in normal bronchial epithelial cells, and the expression was reduced in NSCLC. The expression of p27 was significantly reduced in patients with positive expression of Skp2. Expression of Skp2 was negatively correlated with expression of p27. CONCLUSIONS: The expression of Skp2 is up-regulated in NSCLC, and overexpression of Skp2 reduces the protein level of p27 through ubiquitin-dependent degradation, indicating Skp2 may play an important role in oncogenesis and development of NSCLC.

Key concepts: SKP2, Carcinogenesis, Immunohistochemistry, Cancer research, Lung cancer, Biology, Cell cycle, Kinase

Related papers

Back to paper searchBrowse research topicsOriginal source
[The expression of Skp2 in human non-small cell lung cancer and its correlation with expression of p27 protein.]. — Research Paper | ScholarLens